
Recent progress in patent foramen ovale and related …
Patent foramen ovale (PFO) is a common congenital cardiac abnormality when the opening of the interatrial septum is not closed in adulthood. This abnormality affects 25% of the general population.
Migraine in Patients Undergoing PFO Closure: - JACC: Basic to ...
The association between migraine and patent foramen ovale (PFO) has been documented. We aimed to investigate platelet activation, prothrombotic phenotype, and oxidative stress status of migraineurs with PFO on 100 mg/day aspirin, before and 6 months after PFO closure.
Patent Foramen Ovale Management for Secondary Stroke …
Nov 21, 2023 · Patent foramen ovale (PFO) is frequently identified in young patients with ischemic stroke. Randomized controlled trials provide robust evidence supporting PFO closure in selected patients with cryptogenic ischemic stroke; however, several questions remain unanswered.
Normobaric oxygen may attenuate the headache in patients with …
In this paper, we aim to explore alternative migrained-inhibiting treatments by conducting a real-world self-control study exploring the use of normobaric oxygenation (NBO) as a novel therapy for PFO-migraine treatment.
Patent foramen ovale (PFO) and migraine: role of platelet Tissue …
Oct 3, 2022 · A strong relationship links migraine with aura (MHA) and patent foramen ovale (PFO), with migraine regression after PFO closure. Increased platelet aggregation and oxidative stress were documented in migraineurs.
Migraine in Patients Undergoing PFO Closure: Characterization of …
Apr 13, 2022 · The association between migraine and patent foramen ovale (PFO) has been documented. We aimed to investigate platelet activation, prothrombotic phenotype, and oxidative stress status of migraineurs with PFO on 100 mg/day aspirin, …
Multisite and multitimepoint proteomics reveal that patent …
Aug 12, 2023 · Patent foramen ovale (PFO) is a congenital defect in the partition between two atria, which may cause right-to-left shunt (RLS), leading to neurological chronic diseases with episodic manifestations (NCDEMs), such as migraine and epilepsy.
The Barrier Disruption and Pyroptosis of Intestinal Epithelial Cells ...
Jul 3, 2024 · It reveals that PFO toxins increase ROS production by causing mitochondrial damage, triggering pyroptosis in IPEC-J2 cells, and consequently resulting in compromised intestinal barrier function. These results offer a scientific foundation for developing preventive and therapeutic approaches against C. perfringens infections.
Migraine in Patients Undergoing PFO Closure - PMC - National …
Apr 13, 2022 · The association between migraine and patent foramen ovale (PFO) has been documented. We aimed to investigate platelet activation, prothrombotic phenotype, and oxidative stress status of migraineurs with PFO on 100 mg/day aspirin, …
Practice advisory update summary: Patent foramen ovale and …
To update the 2016 American Academy of Neurology (AAN) practice advisory for patients with stroke and patent foramen ovale (PFO). The guideline panel followed the AAN 2017 guideline development process to systematically review studies published through December 2017 and formulate recommendations.